无人机能提供有效的早期节律控制:使用EAST-AFNET 4标准对ATHENA试验的特点分析
Paulus Kirchhof1,2,3, A John Camm4, Harry J G M Crijns5
1Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
概括
在早期心房动 (AF) 患者中,dronedarone显著降低了心血管事件. 早期的节律控制用dronedarone是支持为选定的早期AF患者.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在ATHENA试验 (NCT00174785) 中,研究了无人机对心房动 (AF) 的治疗.
- 在EAST-AFNET 4试验 (NCT01288352) 中,确定了AF早期节律控制的标准.
研究的目的:
- 评估Dronedarone (每天两次400毫克) 是否改善了患有并发症的早期心房/心房 (AF) 患者的心血管结果.
- 根据EAST-AFNET 4的纳入标准和结果评估dronedarone的疗效和安全性.
主要方法:
- 对ATHENA试验的后期分析,该试验涉及1810名早期AF患者.
- 共同初级结局包括心血管死亡,中风或因心力衰竭/急性冠状动脉综合征住院的综合结果,以及每年住院的夜晚.
- 二级结局是12个月后的鼻节律;初级安全结局是死亡,中风或与节律控制治疗相关的严重不良事件的复合.
主要成果:
- 德罗内达龙显著降低了心血管死亡,中风或住院住院的复合情况 (HR 0.71;P=0.014).
- 两组之间在医院住院的夜晚没有差异.
- 更多的Dronedarone患者实现了鼻节律 (69.2%) 与安慰剂 (60.8%).
- 在Dronedarone和安慰剂组之间,主要安全事件没有显著差异.
结论:
- 在早期AF患者中,德罗内达龙在减少心血管事件方面表现出有效性.
- 这些发现支持在精选的早期AF患者中使用dronedarone的早期节律控制治疗.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
879
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
879
Disturbances in Heart Rhythm
812
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
812
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
695
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
695
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
746
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
746
Pulse rhythm
749
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
749


